COVID-19

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 27, 2023.

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the latest in COVID-19, a CDC shake-up, and the bird flu.

Infection Control Today's® Product Locator is a monthly column highlighting some of the latest advanced technology in the infection prevention field.

Kevin Kavanagh, MD, examines the current bird flu outbreak and the possible dangers it holds for humans.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 20, 2023.

Moderna announced encouraging news about its RSV mRNA-1345 vaccine and plans to submit for regulatory approval in the first half of 2023.

Information for infection preventionists to manage ESBL-producers even while fighting against COVID-19.

Kevin Kavanagh, MD, explains his concern about immunodysfunction and the possibility of its effects on hospitals.

New study shows home infusion therapy staff may have significant barriers to infection-surveillance training, and this could be leading to higher infection rates.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 13, 2023.

How do infection preventionists navigate the many—and often contradictory—requirements that fighting the COVID-19 pandemic has brought upon them?

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the great news about Ebola in Uganda. She also covers COVID-19 news, and what it has to do with the Clash of the Titans.

Have the CDC and EPA given enough correct guidance on how to use cleaning products during the COVID-19 pandemic, or is it “fundamentally flawed”?

How should health care workers, especially infection preventionists, give constructive criticism in their positions?

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 6, 2023.

The public expects infectious disease experts to know how to protect them—and themselves—from getting ill from infectious diseases, including COVID-19. So, what happens when the infectious disease specialist gets ill herself?

The CDC genomic surveillance found that the XBB.1.5 variant has increased from causing 1% to over 40% in only a month.

Even during the COVID-19 pandemic, infection preventionists, nurses, environmental services personnel, and other health care workers cannot forget about C auris.

A recent study attempted to estimate the transmission of SARS-CoV-2 from humans to their pets and identify the risk factors, including food and water bowls and human-animal contact.

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses infectious diseases as the new year begins.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 30, 2022.

Here are the top 5 video interviews from Infection Control Today for 2022.

Here is the most popular ICT® article of 2022.

This last week of 2022, Infection Control Today® reviews the most popular articles. Here are the 4th, 3rd, and 2nd most popular.

Kevin Kavanagh, MD, discusses the continued concerns about COVID-19 vaccine efficacy reduction and what he believes should be done to protect against the further spread.

This last week of 2022, Infection Control Today® reviews the most popular articles. Here are the 7th, 6th, and 5th.

This last week of 2022, Infection Control Today® reviews the most popular articles. Here are the 10th, 9th, and 8th.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 24, 2022.

FDA approved this intravenous tocilizumab (Actemra) for hospitalized adults with COVID-19.

A study from Canada suggests that not being vaccinated for COVID-19 could mean an individual is at higher risk for an automobile accident. What if it is from brain damage from contracting COVID-19?